Wockhardt is currently trading at Rs. 527.00, up by 7.50 points or 1.44% from its previous closing of Rs. 519.50 on the BSE.
The scrip opened at Rs. 529.00 and has touched a high and low of Rs. 540.00 and Rs. 516.25 respectively. So far 80408 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 569.80 on 31-Dec-2020 and a 52 week low of Rs. 147.20 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 540.00 and Rs. 504.25 respectively. The current market cap of the company is Rs. 5885.03 crore.
The promoters holding in the company stood at 72.12%, while Institutions and Non-Institutions held 4.12% and 23.75% respectively.
Wockhardt has been awarded a six-month extension of its agreement with the UK Government to fill-finish COVID-19 vaccines. This expands the original agreement from 18 to 24 months i.e., until August 2022 and the manufacturing will continue to be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.
Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.
